seed
Stage
About
Alphabiome develops AI technology that processes raw, unannotated genetic sequencing data across multiple organisms without relying on reference genomes to predict patient responses to therapies, thereby improving precision medicine and drug development.
Explore Alphabiome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.